ProKidney Corp.

US$1.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PROKHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (33.46%)
Div yield —
ROE (58.96%)
Biotechnology
Beta (5Y) 1.90
PE TTM —
TSR TTM (62.75%)
Mkt cap US$344.6M
ROIC (38.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.28
12.71%
(94.50%)
Hold 11|10|5|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
5.49%
23.09%
14.32%
29.76%
Revenue$M
40.98
41.17
41.67
40.60
5.96%
8.73%
6.50%
1.95%
Peers (US$344.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.162
0.735
0.639
EBIT/Intx
0.886
0.051
0.054
Own earn%
(80.59)
(101.59)
(70.43)
Sh yield%
36.74
19.01
17.71
Owners
Insiders/Inst%
9.73
43.08
Short interest%
3.63
SBC / revenue%
0.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
6–11
$1 testx
−0.3
Incr. ROIC%
1